Cryo Cell International Inc
CCEL NYSE Services-Misc Health & Allied Services, Nec 金融 FY2016–FY2025
最新收盘价 · 2026年10月23日
$4.46
0.8%Cryo Cell International Inc 的业务
暂无业务介绍。
- 法定名称
- CRYO CELL INTERNATIONAL INC
- 财年结束日
- 2025年11月30日
- 最新年报
- 10-K · 2026年2月27日
- 登记号 · CIK
- 0001193125-26-083096
0000862692
营收与利润率
Cryo Cell International Inc 在 2025 财年 营收为 $31.6M,同比下降 1.3%。
净利润与每股收益
亏损期间以红色显示。
资本回报率
税后营业利润占投入业务资金(债务加股东权益减现金)的比例。
现金流
2025 财年 的自由现金流为 $5.2M,占营收的 16.6%。 经营现金流减资本支出。
股息、回购与股数
Cryo Cell International Inc 在 2025 财年 向股东返还 $3.4M,占自由现金流的 65%。 稀释股数减少 1.7%。
资产负债表
现金、债务以及显示 Cryo Cell International Inc 承担债务能力的指标。
| 财年末 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| 现金及短期投资 | $8.3M | $1.7M | $1.0M | $3.5M | $3.3M |
| 债务(含融资租赁) | $1.9M | $8.7M | $8.6M | $8.5M | $8.4M |
| 净债务 / EBITDA | −1.3x | 1.3x | — | 1.2x | 3.4x |
| 债务 / 股东权益 | 0.5x | — | — | — | — |
| 利息保障倍数 | 2.9x | 2.6x | −9.9x | 1.9x | 0.2x |
| 流动比率 | 0.7x | 0.5x | 0.5x | 0.6x | 0.6x |
| 速动比率 | 0.7x | 0.4x | 0.4x | 0.6x | 0.6x |
| 总资产 | $60.7M | $64.9M | $64.7M | $64.7M | $61.7M |
| 总负债 | $56.5M | $66.4M | $72.3M | $77.9M | $80.3M |
| 股东权益 | $4.2M | −$1.5M | −$11.0M | −$13.2M | −$18.6M |
| 净债务 (− = 净现金) | −$6.4M | $7.0M | $7.6M | $5.0M | $5.1M |
内部人交易
高管、董事和持股超过 10% 的股东在公开市场的买卖,数据来自 Form 4 申报。“计划”表示依据事先制定的 Rule 10b5-1 计划进行的交易。
买入(12 个月)
$0.0M
0 名内部人士
卖出(12 个月)
$0.0M
0 名内部人士
卖出中按计划执行的比例
—
$0.0M
过去 12 个月没有公开市场的内部人交易。
Piotroski F 分数
关于盈利能力、融资和效率的九项通过/未通过测试。8–9 为强,0–2 为弱。
| 测试项 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| 净利润为正 | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ |
| 经营现金流为正 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 资产回报率上升 | — | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ |
| 经营现金流高于净利润 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 债务相对资产下降 | — | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ |
| 流动比率上升 | — | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ |
| 股数未增加 | — | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ |
| 毛利率上升 | — | — | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ |
| 营收相对资产上升 | — | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ |
| F 分数 | — / 3 | 7 / 8 | 5 / 9 | 7 / 9 | 8 / 9 | 4 / 9 | 5 / 9 | 6 / 9 | 9 / 9 | 6 / 9 |
| 应计比率 | −32.3% | −15.7% | −18.5% | −9.3% | −10.9% | −10.9% | −9.2% | −28.5% | −8.7% | −12.5% |
| Altman Z'' | −6.16 | −2.62 | −1.40 | −1.07 | 0.03 | −0.95 | −1.69 | −4.17 | −2.39 | −3.07 |
10 年数据
金额单位为 USD。将鼠标悬停在指标名称上可查看定义。
| 财年 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| 利润表 | ||||||||||
| 营收 | $23.1M | $25.4M | $29.2M | $31.8M | $31.1M | $28.9M | $30.3M | $31.3M | $32.0M | $31.6M |
| 毛利 | — | $18.7M | $20.7M | $21.8M | $21.5M | $19.9M | $21.5M | $23.0M | $24.0M | $24.2M |
| 研发支出 | $0.1M | $0.0M | $0.1M | $0.0M | $0.0M | $0.0M | $0.4M | $1.2M | $1.2M | $0.4M |
| 营业利润 | $0.4M | $5.0M | $5.2M | $5.1M | $7.7M | $4.0M | $4.0M | −$12.3M | $3.5M | $0.5M |
| 利息支出 | $0.9M | $1.3M | $1.5M | $1.7M | $1.5M | $1.4M | $1.5M | $1.2M | $1.9M | $2.1M |
| 税前利润 | −$2.5M | $3.6M | $3.6M | $3.4M | $5.0M | $2.6M | $3.3M | −$13.4M | $2.8M | −$2.3M |
| 所得税 | −$1.2M | $1.3M | $4.5M | $1.1M | $1.4M | $0.5M | $0.5M | −$3.8M | $2.4M | $0.1M |
| 净利润 | −$1.3M | $2.3M | −$0.9M | $2.3M | $3.6M | $2.1M | $2.8M | −$9.5M | $0.4M | −$2.4M |
| 稀释每股收益 | −$0.16 | $0.30 | −$0.11 | $0.27 | $0.45 | $0.25 | $0.33 | −$1.14 | $0.05 | −$0.30 |
| 稀释股数 | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| 现金流 | ||||||||||
| 经营现金流 | $5.0M | $5.7M | $5.3M | $6.3M | $8.5M | $7.9M | $8.6M | $8.9M | $6.0M | $5.5M |
| 资本支出 | $0.3M | $0.1M | $0.4M | $0.7M | $0.1M | $1.8M | $12.2M | $6.8M | $2.4M | $0.2M |
| 自由现金流 | $4.6M | $5.6M | $4.9M | $5.6M | $8.4M | $6.1M | −$3.6M | $2.1M | $3.6M | $5.2M |
| 折旧与摊销 | $0.2M | $0.1M | $0.3M | $0.4M | $0.4M | $1.0M | $1.5M | $1.4M | $0.7M | $1.0M |
| 股权激励 | $1.8M | $1.0M | $0.5M | $0.4M | $0.6M | $0.3M | $0.5M | $0.8M | $0.8M | $0.4M |
| 股票回购 | $10.8M | $0.4M | — | $1.0M | — | $0.2M | $1.8M | $0.8M | $1.4M | $0.2M |
| 已付股息 | — | — | — | — | — | $0.0M | $7.7M | $0.0M | $2.0M | $3.2M |
| 股息与回购 | $10.8M | $0.4M | — | $1.0M | — | $0.2M | $9.5M | $0.8M | $3.4M | $3.4M |
| 资产负债表 | ||||||||||
| 现金及短期投资 | $4.1M | $6.7M | $6.9M | $7.4M | $10.4M | $8.3M | $1.7M | $1.0M | $3.5M | $3.3M |
| 总债务 | $9.8M | $7.3M | $12.9M | $9.0M | $5.9M | $1.9M | $8.7M | $8.6M | $8.5M | $8.4M |
| 流动资产 | $9.0M | $12.7M | $14.8M | $15.4M | $18.6M | $15.8M | $9.6M | $9.5M | $12.6M | $11.8M |
| 流动负债 | $13.1M | $13.9M | $15.4M | $15.4M | $16.4M | $21.1M | $19.5M | $20.9M | $21.6M | $19.8M |
| 存货 | $0.4M | $0.3M | $1.3M | $1.1M | $0.9M | $0.9M | $0.9M | $0.8M | $0.7M | $0.4M |
| 固定资产净额 | $1.0M | $0.9M | $1.5M | $1.8M | $1.6M | $3.2M | $13.6M | $21.0M | $21.9M | $21.0M |
| 商誉 | $0.0M | $0.0M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M |
| 无形资产 | $0.3M | $0.2M | $1.3M | $1.2M | $1.2M | $1.6M | $1.5M | $1.0M | $0.9M | $0.9M |
| 总资产 | $19.5M | $23.9M | $42.9M | $42.9M | $46.2M | $60.7M | $64.9M | $64.7M | $64.7M | $61.7M |
| 总负债 | $35.0M | $36.4M | $51.3M | $49.8M | $48.9M | $56.5M | $66.4M | $72.3M | $77.9M | $80.3M |
| 优先股 | — | — | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| 股东权益 | −$15.4M | −$12.5M | −$8.9M | −$7.0M | −$2.7M | $4.2M | −$1.5M | −$11.0M | −$13.2M | −$18.6M |
| 利润率 | ||||||||||
| 毛利率 | — | 73.5% | 70.8% | 68.5% | 69.0% | 68.9% | 71.0% | 73.2% | 75.2% | 76.6% |
| 营业利润率 | 1.9% | 19.7% | 17.8% | 15.9% | 24.6% | 13.9% | 13.3% | −39.3% | 10.9% | 1.5% |
| EBITDA 利润率 | 2.5% | 20.2% | 18.8% | 17.2% | 25.8% | 17.5% | 18.2% | −34.8% | 13.0% | 4.6% |
| 净利率 | −5.7% | 9.1% | −2.9% | 7.2% | 11.6% | 7.2% | 9.1% | −30.4% | 1.3% | −7.7% |
| 自由现金流利润率 | 20.1% | 22.1% | 16.7% | 17.7% | 26.9% | 21.1% | −11.9% | 6.6% | 11.3% | 16.6% |
| 回报率 | ||||||||||
| 资本回报率 | — | — | — | — | — | — | 61.3% | — | — | — |
| 已动用资本回报率 | 6.7% | 50.2% | 18.9% | 18.4% | 25.7% | 10.1% | 8.9% | −28.1% | 8.1% | 1.2% |
| 股本回报率 | — | — | — | — | — | 274.3% | 208.4% | — | — | — |
| 资产回报率 | −6.8% | 10.7% | −2.6% | 5.3% | 8.1% | 3.9% | 4.4% | −14.7% | 0.6% | −3.8% |
| 有形股本回报率 | — | — | — | — | — | 305.0% | — | — | — | — |
| 增长 | ||||||||||
| 营收增长 | — | 9.8% | 15.1% | 8.9% | −2.1% | −7.3% | 5.0% | 3.3% | 2.0% | −1.3% |
| 净利润增长 | — | — | −136.9% | — | 58.2% | −42.5% | 33.0% | −443.6% | — | −704.2% |
| 每股收益增长 | — | — | −136.7% | — | 66.7% | −44.4% | 32.0% | −445.5% | — | −700.0% |
| 自由现金流增长 | — | 21.0% | −13.0% | 15.3% | 48.5% | −27.2% | −159.0% | — | 73.4% | 45.5% |
| 股数变化 | — | −5.7% | −2.5% | 12.7% | −3.2% | 2.7% | 1.5% | −1.7% | −1.5% | −1.7% |
| 财务健康 | ||||||||||
| 净债务 / EBITDA | 9.7x | 0.1x | 1.1x | 0.3x | −0.6x | −1.3x | 1.3x | — | 1.2x | 3.4x |
| 债务 / 股东权益 | — | — | — | — | — | 0.5x | — | — | — | — |
| 利息保障倍数 | 0.5x | 3.8x | 3.4x | 3.0x | 5.0x | 2.9x | 2.6x | −9.9x | 1.9x | 0.2x |
| 流动比率 | 0.7x | 0.9x | 1.0x | 1.0x | 1.1x | 0.7x | 0.5x | 0.5x | 0.6x | 0.6x |
| 速动比率 | 0.7x | 0.9x | 0.9x | 0.9x | 1.1x | 0.7x | 0.4x | 0.4x | 0.6x | 0.6x |
| 资本配置 | ||||||||||
| 资本支出 / 营收 | 1.5% | 0.4% | 1.5% | 2.1% | 0.3% | 6.3% | 40.1% | 21.8% | 7.5% | 0.7% |
| 股权激励 / 营收 | 7.7% | 3.8% | 1.6% | 1.3% | 2.0% | 1.0% | 1.5% | 2.6% | 2.4% | 1.3% |
| 股东回报 / 自由现金流 | 232.6% | 7.9% | — | 17.6% | — | 4.1% | — | 38.4% | 95.5% | 64.8% |
| 质量评分 | ||||||||||
| Piotroski F 分数 | — | 7.0 | 5.0 | 7.0 | 8.0 | 4.0 | 5.0 | 6.0 | 9.0 | 6.0 |
| Altman Z'' | −6.2 | −2.6 | −1.4 | −1.1 | 0.0 | −0.9 | −1.7 | −4.2 | −2.4 | −3.1 |
| 应计比率 | −32.3% | −15.7% | −18.5% | −9.3% | −10.9% | −10.9% | −9.2% | −28.5% | −8.7% | −12.5% |
来源:SEC EDGAR XBRL 文件 (CIK 0000862692). 数据更新于 2026年10月24日。 第四季度数据为全年减去前九个月。 仅供参考,不构成投资建议。依赖任何数字前,请核对原始文件。
